Aehr Test Systems carries a market capitalization of 3.74B, placing it among publicly traded companies globally. Its enterprise value stands at 1.10B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.74B |
| Enterprise Value | 1.10B |
Aehr Test Systems currently has 30.95M shares outstanding.
| Shares Outstanding | 30.95M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 24.94, and the price-to-book ratio stands at -36.10.
| PE Ratio | N/A |
| PS Ratio | 24.94 |
| PB Ratio | -36.10 |
| P/TBV Ratio | 9.55 |
| P/FCF Ratio | -418.96 |
| P/OCF Ratio | -151.62 |
| EV / Sales | 24.35 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Aehr Test Systems maintains a current ratio of 10.97, meaning it holds 11.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 10.97 |
| Quick Ratio | 5.57 |
| Debt / Equity | 7.22 |
| Debt / EBITDA | -0.86 |
| Interest Coverage | N/A |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -7.63 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.74 |
| Income Tax | -2.85M |
| Effective Tax Rate | N/A |
Aehr Test Systems's stock has gained approximately 910.27165% over the past 52 weeks. The 50-day moving average sits at 89.70, while the 200-day moving average is 43.49.
| Beta (5Y) | N/A |
| 52-Week Price Change | 910.27165% |
| 50-Day Moving Average | 89.70 |
| 200-Day Moving Average | 43.49 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Aehr Test Systems generated 45.26M in revenue and converted that into -11.42M in net income, yielding earnings per share of -0.38. EBITDA reached -11.60M, while operating income came in at -15.28M.
| Revenue | 45.26M |
| Gross Profit | 13.90M |
| Operating Income | -15.28M |
| Pretax Income | -14.27M |
| Net Income | -11.42M |
| EBITDA | -11.60M |
| EBIT | -15.28M |
| Earnings Per Share (EPS) | -0.38 |
Aehr Test Systems holds 36.91M in cash and equivalents against 10.03M in total debt, resulting in a net debt position of -36.91M. Total book value stands at -31.27M, with working capital of 87.16M providing operational flexibility.
| Cash & Cash Equivalents | 36.91M |
| Total Debt | 10.03M |
| Net Debt | -36.91M |
| Equity (Book Value) | -31.27M |
| Book Value Per Share | -1.04 |
| Working Capital | 87.16M |
Aehr Test Systems produced -7.44M in operating cash flow over the past twelve months. After subtracting -4.75M in capital expenditures, free cash flow totaled -12.19M - equivalent to -0.40 per share.
| Operating Cash Flow | -7.44M |
| Capital Expenditures | -4.75M |
| Free Cash Flow | -12.19M |
| FCF Per Share | -0.40 |
Aehr Test Systems operates with a gross margin of 30.72, reflecting its pricing power and cost economics. The operating margin of -33.76 and net profit margin of -25.23 provide insight into operational efficiency.
| Gross Margin | 30.72 |
| Operating Margin | -33.76 |
| Pretax Margin | -31.53 |
| Profit Margin | -25.23 |
| EBITDA Margin | -25.64 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -1.75 |
| FCF Yield | -0.24 |
Aehr Test Systems posts an Altman Z-Score of 37.50, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 37.50 |